Discover 1,170 paid clinical trials in Montreal, Quebec. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,170
A Study of Lorigerlimab in Participants With Advanced Solid Tumors
for
Platinum-resistant Ovarian Cancer,
Location: Montreal, Toronto, Pittsburgh PA, Grand Rapids MI,
Sponsor: MacroGenics
Sex: Female
Age: 18+
Code: NCT06730347
Phase2, Recruiting
Secondary Prevention of Clostridioides Difficile Using Vancomycin
for
Clostridioides Difficile Infection,
Location: Montreal
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre
Sex: All
Age: 18+
Code: NCT06979609
Phase2, Phase3, Recruiting
Study of an Injectable Regimen of GS-3242 With Lenacapavir Compared to Biktarvy in People New to HIV-1 Treatment
for
HIV-1-infection
Location: Montreal, Decatur GA, Kansas City MO, Florida City FL,
Sponsor: Gilead Sciences
Sex: All
Age: 18+
Code: NCT07708727
Phase2, Phase3, Recruiting
Combined Malonic and Methylmalonic Aciduria (CMAMMA): Gene Identification and Outcome Study
for
Malonic Aciduria, Methylmalonic Acidemia
Location: Montreal
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre
Sex: All
Age: 0+
Code: NCT01289158
Recruiting
Non-invasive Diagnosis of Non-alcoholic Steatohepatitis in Liver Transplant Recipients
for
Non-alcoholic Fatty Liver Disease
Location: Montreal
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre
Sex: All
Age: 18+
Code: NCT03128918
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study to Investigate the Safety and Efficacy of SAR446523 Injected Subcutaneously in Adult Participants With Relapsed/Refractory Myeloma
for
Plasma Cell Myeloma Refractory
Location: Montreal, Sherbrooke, Hackensack NJ, Philadelphia PA,
Sponsor: Sanofi
Sex: All
Age: 18+
Code: NCT06630806
Phase1, Recruiting
Evaluation of Efficacy and Safety of Early in Hospital Initiation of Inclisiran Treatment in Patients With Acute Coronary Syndromes
for
Acute Coronary Syndrome
Location: Montreal, Quebec, Hamilton, Edmonton
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07102628
Phase3, Recruiting
Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
Location: Fredericton, Richmond Hill, Toronto, Montreal, Quebec,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06382051
Recruiting
A Study to Investigate the Safety and Tolerability of Oral INR731 Single Agent or in Combination With Androgen Receptor Pathway Inhibitor (ARPI) in Patients With Metastatic Prostate Cancer
for
Metastatic Castration-resistant Prostate Cancer (mCRPC)
Location: Montreal, Dallas TX
Sponsor: Novartis Pharmaceuticals
Sex: Male
Age: 18+
Code: NCT07570979
Phase1, Recruiting
Remibrutinib Open Label Roll-over Post-trial Access Protocol
for
Indication of the Parent Protocol
Location: Quebec, Verdun, Hamilton, London
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18 - 70+
Code: NCT07456891
Phase3, Recruiting
Rollover Study for Participants Who Have Been Treated With and Are Continuing to Benefit From Opnurasib as a Single Agent or in Combination With Other Study Treatments
for
Locally Advanced or Metastatic KRAS G12C-mutated Non-small Cell Lung Cancer,
Location: Montreal
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18 - 70+
Code: NCT07468071
Phase1, Phase2, Recruiting
Phase I Study of [177Lu]Lu-DFC413 in Patients With Solid Tumors
Real-world Secukinumab Outcomes in Canadian HS Patients
for
Hidradenitis Suppurativa
Location: Fredericton, Richmond Hill, Sherbrooke, Saint-Jerôme,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18 - 70+
Code: NCT07282015
Recruiting
STOP-HAE: A Phase 3 Study of ADX-324 in HAE
for
Hereditary Angioedema, HAE, Hereditary Angioedema - Type 1,
Location: Montreal, New York NY, Hershey PA, Chevy Chase MD,
Sponsor: ADARx Pharmaceuticals, Inc.
Sex: All
Age: 18+
Code: NCT06960213
Phase3, Recruiting
Development of a Novel Functional Eye-Tracking Software Application for Multiple Sclerosis
for
Multiple Sclerosis
Location: Montreal
Sponsor: Innodem Neurosciences
Sex: All
Age: 18+
Code: NCT05061953
Recruiting
A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
for
Chronic Inflammatory Demyelinating Polyneuropathy
Location: Montreal, Burlington VT, Quebec, Boston MA,
Sponsor: Sanofi
Sex: All
Age: 18+
Code: NCT06290141
Phase3, Recruiting
LND101 for Fecal Microbiota Transplantation in Combination With Immune Checkpoint Blockade in Advanced Melanoma
for
Melanoma
Location: Montreal, Greenfield Park, Trois-Rivieres, Ottawa,
Sponsor: Canadian Cancer Trials Group
Sex: All
Age: 18+
Code: NCT06623461
Phase2, Recruiting
Alleviant ALLAY-HF Study
for
Heart Failure
Location: Montreal, Boston MA, Newmarket, Stony Brook NY,